MedPath

Comparison of two prostatectomy methods

Not Applicable
Recruiting
Conditions
Benign prostate hyperplasia.
Hyperplasia of prostate
Registration Number
IRCT20180305038956N1
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
100
Inclusion Criteria

The classical indications for prostate surgery
Patients with prostate size between 30 and 70 grams
Complete the informed consent form by the patient

Exclusion Criteria

Previous prostate surgery with high PSA (Prostate Specific Antigen) Levels
Uncontrolled diabetes
History of CVA (cerebral vascular accident) and neurological diseases
Urinary tract obstruction
Addiction
Use of neurological and anticholinergic drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Benign prostatic hyperplasia. Timepoint: One week after surgery, then one month, 3 months and 6 months after surgery. Method of measurement: The amount of Q-Max (Maximum urinary flow) in the uroflowmetry before and after the surgery.
Secondary Outcome Measures
NameTimeMethod
Bleeding. Timepoint: During surgery, up to a week later. Method of measurement: The rate of receiving blood during and after surgery, and expert examination.;Wound infection. Timepoint: One week after surgery, then up to 1 month after surgery. Method of measurement: Expert examination.;Duration of catheterization after surgery. Timepoint: 1,3,7 days after surgery. Method of measurement: Expert examination.;Urethral stricture. Timepoint: 1 week, 1 month and 3 months after surgery. Method of measurement: Expert examination and retrograde urethrography.
© Copyright 2025. All Rights Reserved by MedPath